1. Home
  2. TIPT vs IRWD Comparison

TIPT vs IRWD Comparison

Compare TIPT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiptree Inc.

TIPT

Tiptree Inc.

HOLD

Current Price

$17.22

Market Cap

634.8M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.43

Market Cap

526.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIPT
IRWD
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
634.8M
526.7M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
TIPT
IRWD
Price
$17.22
$4.43
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
208.3K
1.9M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
1400.00
EPS
0.76
0.15
Revenue
$488,000.00
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
N/A
$4.39
P/E Ratio
$22.67
$29.13
Revenue Growth
N/A
8.88
52 Week Low
$15.49
$0.55
52 Week High
$27.38
$5.78

Technical Indicators

Market Signals
Indicator
TIPT
IRWD
Relative Strength Index (RSI) 57.03 67.79
Support Level $17.15 $3.07
Resistance Level $18.15 $5.67
Average True Range (ATR) 0.32 0.23
MACD 0.09 0.12
Stochastic Oscillator 79.59 98.94

Price Performance

Historical Comparison
TIPT
IRWD

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: